Patents by Inventor Weixing Zhang

Weixing Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12247036
    Abstract: The present invention relates to compounds of formula (Ib), wherein R1 to R3, M and L are as described herein, and their pharmaceutically acceptable salt, enantiomers and diastereomers thereof, and compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: August 22, 2024
    Date of Patent: March 11, 2025
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jianguo Chen, Lei Guo, Haixia Liu, Hong Shen, Junwei Xi, Weixing Zhang, Dan Zhao, Wei Zhu
  • Publication number: 20240417410
    Abstract: The present invention relates to compounds of formula (Ib), wherein R1 to R3, M and L are as described herein, and their pharmaceutically acceptable salt, enantiomers and diastereomers thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 22, 2024
    Publication date: December 19, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jianguo CHEN, Lei GUO, Haixia LIU, Hong SHEN, Junwei XI, Weixing ZHANG, Dan ZHAO, Wei ZHU
  • Patent number: 12060333
    Abstract: The present invention relates to compounds of formula (I), wherein R1-R5 and L are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: August 13, 2024
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Chungen Liang, Hongying Yun, Weixing Zhang, Kun Miao, Jianguo Chen, Yao Wu
  • Publication number: 20240012784
    Abstract: This application provides a data transmission apparatus and a data transmission method. The data transmission apparatus in this application includes: a first connection unit and a control unit, where the first connection unit is a connector plug or a connector socket; and the control unit is configured to: if determining that the first connection unit is in a forward insertion state, control a first data pin pair of the first connection unit to be in a first communication mode, and control a second data pin pair of the first connection unit to be in a second communication mode.
    Type: Application
    Filed: September 21, 2023
    Publication date: January 11, 2024
    Inventors: Deng Lu, Zhaohua Qian, Weixing Zhang, Jiandong Ke
  • Publication number: 20230376436
    Abstract: An apparatus with a forward-reverse insertion interface and a detection method are provided, and relate to the field of communication technologies, to improve transmission efficiency of an auxiliary channel. The forward-reverse insertion interface of the apparatus includes: a first auxiliary channel (CH1), including a first switch selection circuit (SW1) coupled to a first node (A); a second auxiliary channel (CH2), including a second switch selection circuit (SW2) coupled to a second node (B), where the second switch selection circuit (SW2) and the first switch selection circuit (SW1) are structurally asymmetrical; and a control circuit (CTRL), configured to control switching of the first switch selection circuit (SW1) to change an electrical parameter of the first node (A), and control switching of the second switch selection circuit (SW2) to change an electrical parameter of the second node (B).
    Type: Application
    Filed: July 28, 2023
    Publication date: November 23, 2023
    Inventors: Weixing ZHANG, Zhaohua QIAN, Jiandong KE
  • Publication number: 20230279001
    Abstract: The present invention relates to compounds of formula (I), wherein R1, R2, R3, R4, R5 and A are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 2, 2021
    Publication date: September 7, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Dongdong CHEN, Jianguo CHEN, Fabian DEY, Xin HONG, Xuefei TAN, Jiasu XU, Weixing ZHANG, Wei ZHU, Ge ZOU
  • Patent number: 11720629
    Abstract: The present invention provides a knowledge graph construction method and device. The method includes: obtaining structured data, where the structured data includes a first entity name of a first entity and attribute information corresponding to the first entity name, and the attribute information includes a first attribute and a first attribute value; performing, based on measurement of a similarity between the first entity and a second entity in a knowledge graph, entity alignment processing on the first entity, where the measurement of the similarity includes at least one of the following types: measurement of a character similarity, measurement of a structure similarity of a classification tree on which an entity is located, and measurement of an attribute similarity; and importing the structured data into the knowledge graph according to an entity alignment processing result. Embodiments may ensure correctness of data in the knowledge graph.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: August 8, 2023
    Assignee: ALIBABA GROUP HOLDING LIMITED
    Inventors: Yue Wang, Wei You, Weixing Zhang, Nengwei Hua
  • Patent number: 11713327
    Abstract: The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: August 1, 2023
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Fabian Dey, Buyu Kou, Haixia Liu, Hong Shen, Xiaoqing Wang, Weixing Zhang, Zhisen Zhang, Zhiwei Zhang, Wei Zhu
  • Publication number: 20230022297
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds act as antagonists of the toll-like receptors TLR7, TLR8 and/or TLR9 and are thus useful in the treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Application
    Filed: December 1, 2020
    Publication date: January 26, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jianguo CHEN, Fabian DEY, Hongtao XU, Weixing ZHANG, Wei ZHU
  • Publication number: 20230002415
    Abstract: The present invention relates to compounds of formula (I), wherein R1, R3, Y and A are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: November 18, 2020
    Publication date: January 5, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jianguo CHEN, Weixing ZHANG, Zhisen ZHANG, Wei ZHU
  • Publication number: 20220363665
    Abstract: The present invention relates to compounds of formula (I), (I), wherein R1, R2 and R3 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: September 9, 2020
    Publication date: November 17, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Haixia LIU, Hong SHEN, Weixing ZHANG, Zhiwei ZHANG, Wei ZHU
  • Publication number: 20220075507
    Abstract: A method and a device for controlling a remotely controlled mobile platform and a readable storage medium are provided. The method includes: displaying at least one function icon and at least one control icon, where the function icon represents a control program for implementing a preset function, and the control icon is used to control a control terminal and/or a remotely controlled mobile platform to execute the control program; generating, based on a selection operation of a user on the function icon, the control program associated with the selected function icon; and controlling, based on an operation of the user on the control icon, the control terminal and/or the remotely controlled mobile platform to execute the control program.
    Type: Application
    Filed: November 13, 2021
    Publication date: March 10, 2022
    Applicant: SZ DJI TECHNOLOGY CO., LTD.
    Inventors: Haoyu LI, Junfeng WU, Weixing ZHANG, Yana GUO, Zeyang FAN
  • Publication number: 20220064128
    Abstract: The present invention relates to compounds of formula (I), wherein R1-R5 and L are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 26, 2021
    Publication date: March 3, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Chungen Liang, Hongying Yun, Weixing Zhang, Kun Miao, Jianguo Chen, Yao Wu
  • Publication number: 20210395239
    Abstract: The present invention relates to compounds of formula (I), wherein R1 to R3, A and Q are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: September 25, 2019
    Publication date: December 23, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Jianguo CHEN, Haixia LIU, Yafei LIU, Hong SHEN, Weixing ZHANG, Zhiwei ZHANG, Wei ZHU
  • Publication number: 20210323977
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 28, 2018
    Publication date: October 21, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: HAIXIA LIU, GUOLONG WU, WEIXING ZHANG, WEI ZHU, HONG SHEN, FABIAN DEY
  • Publication number: 20210309658
    Abstract: The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: May 26, 2021
    Publication date: October 7, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Yimin HU, Yongqiang LIU, Hong SHEN, Houguang SHI, Xuefei TAN, Shixiang YAN, Weixing ZHANG, Zhiwei ZHANG, Chengang ZHOU, Mingwei ZHOU, Wei ZHU
  • Publication number: 20210309657
    Abstract: The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: May 26, 2021
    Publication date: October 7, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Yimin HU, Yongqiang LIU, Hong SHEN, Houguang SHI, Xuefei TAN, Shixiang YAN, Weixing ZHANG, Zhiwei ZHANG, Chengang ZHOU, Mingwei ZHOU, Wei ZHU
  • Publication number: 20210300947
    Abstract: The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: June 11, 2019
    Publication date: September 30, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: FABIAN DEY, BUYU KOU, HAIXIA LIU, HONG SHEN, XIAOQING WANG, WEIXING ZHANG, ZHISEN ZHANG, ZHIWEI ZHANG, WEI ZHU
  • Publication number: 20210253575
    Abstract: The present invention relates to compounds of formula (I), wherein R1, R2, R3 and R4 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 19, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian Dey, Haixia Liu, Hong Shen, Guolong Wu, Weixing Zhang, Wei Zhu
  • Publication number: 20210248362
    Abstract: An image-recognition-based control method includes calling an imaging device of a shooting device to collect an environment image of an environment where the shooting device is currently located; calling a preset human-body-feature-part detection model to perform image area identification on the environment image to provide an identification result; and prohibiting a shooting member of the shooting device from shooing, in response to the identification result indicating that the environment image contains a target image area including a preset human-body-feature-part.
    Type: Application
    Filed: April 27, 2021
    Publication date: August 12, 2021
    Inventors: Lei PANG, Weixing ZHANG, Zheng KUANG